KSAT

Women celebrate FDA removal of black box warning on hormone replacement therapy products

For decades, hormone replacement therapies carried warnings that they increased the risk of cancer and dementia. Now, that ...
The American Journal of Managed Care

FDA Approves Sevabertinib for Nonsquamous NSCLC

The FDA has granted an accelerated approval for the use of sevabertinib in patients with nonsquamous non–small cell lung cancer (NSCLC) whose tumors have HER2 ( ERBB2) tyrosine kinase domain (TKD) ...

US FDA approves Bayer's drug for type of lung cancer

The U.S. Food and Drug Administration on Wednesday said it has approved Bayer's drug for patients with a type of lung cancer ...
Healio

FDA grants 510(k) clearance for TMS as adjunctive for major depressive disorder in young people

The FDA has granted 510(k) clearance and a label expansion for a transcranial magnetic stimulation device to treat patients ...

Amgen Lung Cancer Drug Gets Full Approval From FDA

Amgen's Imdelltra received full approval from the Food and Drug Administration for use in patients with lung cancer. The biotechnology company said Wednesday Imdelltra received approval for adult ...
Fierce Pharma

Bayer edges onto Boehringer's turf with FDA nod for HER2-mutated lung cancer med Hyrnuo

Just a few months after Boehringer Ingelheim broke into the oncology space with the first drug that can target a rare tumor ...
Healio

FDA approves epcoritamab for two follicular lymphoma indications

The FDA approved epcoritamab-bysp in combination with lenalidomide and rituximab for patients with relapsed or refractory ...
Health on MSN

4 Things to Know About Hormone Therapy As FDA Removes Black Box Warning

The FDA is removing any mention of risks related to breast cancer, heart disease, and dementia on hormone therapy products ...

FDA Limits Duchenne Gene Therapy After Two Teens Die of Liver Failure

MONDAY, Nov. 17, 2025 (HealthDay News) — The U.S. Food and Drug Administration (FDA) is tightening restrictions on a gene ...

US FDA approves Bayer drug for specific type of lung cancer

The U.S. Food and Drug Administration said on Wednesday that it has approved Bayer's drug for patients with a form of lung ...